down arrow

Hind.Bio Science

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE597C01021
  • NSEID:
  • BSEID: 532041
INR
9.45
0.61 (6.9%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 2.15 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 395126,
    "name": "Hind.Bio Science",
    "stock_name": "Hind.Bio Science",
    "full_name": "Hindustan Bio Sciences Ltd",
    "name_url": "stocks-analysis/hindbio-science",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.45",
    "chg": 0.61,
    "chgp": "6.9%",
    "dir": 1,
    "prev_price": "8.84",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532041,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE597C01021",
    "curr_date": "Apr 11, 12:51 PM",
    "curr_time": "01:06 AM",
    "bse_nse_vol": "2.15 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hindbio-science-395126-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Hindustan Bio Sciences Reports Stable Q3 FY24-25 Results with Strong Debtors Turnover Ratio",
        "link": "https://www.marketsmojo.com/news/result-analysis/hindustan-bio-sciences-reports-flat-q3-results-debtors-turnover-ratio-reaches-22-40-times-495714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/1/HindustanBioSci_quaterlyResult_300863.png",
        "date": "2025-01-30 18:46:04",
        "description": "Hindustan Bio Sciences has announced its financial results for Q3 FY24-25, showcasing stable performance and significant operational metrics. The Debtors Turnover Ratio reached 22.40 times, marking the highest turnover rate in recent periods, indicating effective management of receivables and debt settlement."
      }
    ],
    "total": 6,
    "sid": "395126",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/hindustan-bio-sciences-395126"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2025",
      "details": "Certificate Under Reg. 74 (5)",
      "source": "BSE"
    },
    {
      "caption": "Disclosures Under Regulation 31 (4) Of SEBI (SAST) Regulations 2011",
      "datetime": "08-Apr-2025",
      "details": "Disclosures under regulation 31(4) of SEBI (SAST) regulations 2011",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Mar-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Apr-2025 | Source : BSE

Certificate Under Reg. 74 (5)

Disclosures Under Regulation 31 (4) Of SEBI (SAST) Regulations 2011

08-Apr-2025 | Source : BSE

Disclosures under regulation 31(4) of SEBI (SAST) regulations 2011

Closure of Trading Window

29-Mar-2025 | Source : BSE

Closure of Trading Window

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available